120
Participants
Start Date
February 4, 2025
Primary Completion Date
August 31, 2031
Study Completion Date
September 30, 2031
RiTUXimab Injection
Dose administered will depend on randomisation and for experimental Arm on the risk of having undetectable rituximab level after 3 months
RECRUITING
CHU de BESANCON, Besançon
RECRUITING
CHU de BORDEAUX - Hôpital Pellegrin, Bordeaux
RECRUITING
CHU de CAEN, Caen
RECRUITING
AP-HP - Hôpital H. Mondor, Créteil
RECRUITING
HCL - Hôpital E. Herriot, Lyon
RECRUITING
AP-HM - Hôpital de la Conception, Marseille
RECRUITING
CHU de NICE, Nice
RECRUITING
CHU de Nîmes - Hôpital CAREMEAU, Nîmes
NOT_YET_RECRUITING
AP-HP - Hôpital Européen Georges Pompidou, Paris
NOT_YET_RECRUITING
AP-HP - Hôpital Necker, Paris
RECRUITING
CHU de TOULOUSE - Hôpital Rangueil, Toulouse
RECRUITING
CHRU de TOURS - Hôpital Bretonneau, Tours
NOT_YET_RECRUITING
CH de Valenciennes, Valenciennes
Centre Hospitalier Universitaire de Nice
OTHER